StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · NIKI·Healthcare

Niki BioSolutions, Inc. Stock Analysis & AI Score

Niki BioSolutions, Inc. (NIKI) has an ST Score of 37.7 (C), driven by its Profitability (A+) and held back by its Financial Strength (F). NIKI last traded at $4.97.

Market Closed
$4.97
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
38
ST Score
37.7/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

NIKI
37.7out of 100
Grade C

Niki BioSolutions, Inc. (NIKI) has an ST Score of 37.7 (C), driven by its Profitability (A+) and held back by its Financial Strength (F). NIKI last traded at $4.97.

Strongest
ProfitabilityA+
Weakest
Financial StrengthF
All factor grades
  • ProfitabilityA+
  • ValuationB-
  • GrowthC+
  • MomentumD
  • Financial StrengthF
  • Piotroski1/9
Score methodology
Press Releases

Contact

NIKI stock: frequently asked questions

What is NIKI's ST Score?

Niki BioSolutions, Inc. (NIKI) has an ST Score of 37.7 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is NIKI a buy, hold, or sell?

Our ST Score grades it C (37.7/100). The ST Score is a data-driven signal, not a recommendation.

What are NIKI's factor grades?

Valuation B-, Profitability A+, Financial Strength F, Momentum D, Growth C+.

What is NIKI's valuation grade?

Niki BioSolutions, Inc. (NIKI) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is NIKI's growth grade?

Niki BioSolutions, Inc. (NIKI) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is NIKI's profitability grade?

Niki BioSolutions, Inc. (NIKI) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is NIKI's financial strength grade?

Niki BioSolutions, Inc. (NIKI) earns a financial strength grade of F, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is NIKI's Piotroski score?

Niki BioSolutions, Inc. (NIKI) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.